Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on remdesivir across several countries due to report by the end of April.
Dawa zilizorejeshwa za kuzuia virusi zinaunda utafiti mwingi wa Wachina, na majaribio 9 ya Awamu ya Tatu juu ya remdesivir katika nchi kadhaa kutokana na kuripotiwa mwishoni mwa Aprili.